Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease

Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease

Abstract Background Increased plasma level of lipoprotein(a) (Lpa) is a risk factor of cardiovascular diseases. This study aimed to explore the role of Lpa in the progression of atherosclerosis in patients with end-stage renal disease (ESRD) and to investigate whether its potential mechanism is medi...

Full description

Bibliographic Details
Main Authors: Kun Ling Ma, Tie Kai Gong, Ze Bo Hu, Yang Zhang, Gui Hua Wang, Liang Liu, Pei Pei Chen, Jian Lu, Chen Chen Lu, Bi Cheng Liu
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Nephrology
Subjects:
Lipoprotein (a)
Atherosclerosis
LDLr
CXCL16
End-stage renal disease
Online Access:http://link.springer.com/article/10.1186/s12882-018-0986-2

Internet

http://link.springer.com/article/10.1186/s12882-018-0986-2

Similar Items